Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines
Crossref DOI link: https://doi.org/10.1186/s12933-017-0648-x
Published Online: 2018-01-08
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Packer, Milton https://orcid.org/0000-0003-1828-2387
